Jade Biosciences (JBIO) Payables (2020 - 2026)
Jade Biosciences (JBIO) posted Payables of $4.0 million for Q1 2026, up 84.98% on a QoQ basis from $2.2 million in Q4 2025, and up 5666.67% year-over-year from $69000.0 in Q1 2025.
Jade Biosciences (JBIO) Payables (2020 - 2026) Analysis & Trends
Jade Biosciences' Payables history runs 7 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- Quarterly Payables rose 5666.67% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 5666.67% YoY) and the FY2025 annual result came in at $2.2 million, up 66.74% from the prior year.
- Payables was $4.0 million for Q1 2026 at Jade Biosciences, up from $2.2 million in the prior quarter.
- Across five years, Payables topped out at $7.6 million in Q2 2025 and bottomed at $69000.0 in Q1 2025.
- A 5-year average of $3.1 million and a median of $2.9 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2025 — Payables sank 97.92% — and 2026, when it surged 5666.67%.
- Jade Biosciences' Payables stood at $2.6 million in 2022, then fell by 6.95% to $2.4 million in 2023, then slumped by 46.16% to $1.3 million in 2024, then soared by 66.74% to $2.2 million in 2025, then surged by 84.98% to $4.0 million in 2026.
- Business Quant data shows JBIO's Payables at $4.0 million in Q1 2026, $2.2 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | 3.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.98 Mn |
| Dec 31, 2025 | 2.15 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 7.59 Mn |
| Mar 31, 2025 | 69,000.00 |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 908,000.00 |
| Jun 30, 2024 | 4.18 Mn |
| Mar 31, 2024 | 3.31 Mn |
| Dec 31, 2023 | 2.40 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 5.53 Mn |
| Mar 31, 2023 | 4.73 Mn |
| Dec 31, 2022 | 2.58 Mn |
| Sep 30, 2022 | 4.54 Mn |
| Jun 30, 2022 | 2.07 Mn |
| Mar 31, 2022 | 2.86 Mn |
| Dec 31, 2021 | 1.21 Mn |
| Sep 30, 2021 | 2.56 Mn |
| Jun 30, 2021 | 3.04 Mn |